Health and FitnessHealth and Fitness
Tue, September 13, 2011
[ Tue, Sep 13th 2011 ] - Market Wire
Merck Statement on GARDASIL®
[ Tue, Sep 13th 2011 ] - Market Wire
Time to Teach Savings,;; Too
[ Tue, Sep 13th 2011 ] - Market Wire
EA Sports NHL 12 in Stores Now

AMRI CFO to Present at UBS Global Life Sciences Conference


Published on 2011-09-13 05:05:50 - Market Wire
  Print publication without navigation


ALBANY, N.Y.--([ BUSINESS WIRE ])--AMRI (NASDAQ: AMRI) announced today that AMRI Senior Vice President, Administration and Chief Financial Officer Mark T. Frost will present at the UBS Global Life Sciences Conference on Monday, September 19 at 10:30 a.m. ET.

An audio webcast of the corporate presentation will be available to investors and interested parties by accessing the companya™s website at [ www.amriglobal.com ]. A replay of the webcast will be available immediately after the live webcast through December 16, 2011.

Founded in 1991, Albany Molecular Research, Inc. (AMRI) provides scientific services, products and technologies focused on improving the quality of life. AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for many of the world's leading healthcare companies. As an additional value added service to its customers, the company is also investing in R&D in order to expand its contract services and to identify novel early stage drug candidates with the goal to outlicense to a strategic partner. With locations in the United States, Europe, and Asia, AMRI provides customers with a wide range of services, technologies and cost models.